Diabetics Exposed to Common Household Chemicals Have Lower Heart Disease Rates, Study Finds
Science Daily: “The Centers for Disease Control and Prevention deemed exposure to perfluoroalkyl substances — a class of chemicals used in cookware, cleaning products and paint — a public health concern. But new research explores how exposure to PFAS may be linked to lower heart disease rates in diabetic adults.” Click here for full story.
D2d: Vitamin D Doesn’t Stop Diabetes in Those With Prediabetes
Medscape: “Vitamin D3 supplementation in people at high risk of developing diabetes but who did not have vitamin D insufficiency does not reduce the chances of developing the disease compared with placebo, the new results of a randomized, placebo-controlled trial show.” Click here for full story.
IDegLira Offers Durable Benefit in Uncontrolled T2D
MedPage Today: “Insulin degludec plus liraglutide (IDegLira) was more durable than insulin glargine (IGlar U100) in maintaining glycemic control in patients with uncontrolled type 2 diabetes on oral antidiabetic drugs, a researcher reported here.” Click here for full story.
Healio: “Having diabetes has long been known to increase the risk of certain pregnancy-related complications — risks that can often be minimized by optimizing blood glucose control. But according to a new study, one group is particularly hard-hit by complications during pregnancy and childbirth: teenagers.” Click here for full story.
Liraglutide Preserves Beta-Cell Function in New Type 1 Diabetes
Medscape: “The glucagon-like peptide-1 (GLP-1) agonist liraglutide (Victoza, Novo Nordisk) taken every day preserved postprandial insulin secretion for 1 year after type 1 diabetes diagnosis in patients in the NewLira trial, while the effects disappeared 6 weeks after treatment stopped.” Click here for full story.
B Vitamins May Lower Type 2 Diabetes Risk, Intake Order May Impact Onset
Healio: “Researchers linked consumption of vitamins B2 and B6 to a lower risk for type 2 diabetes, according to a study presented at Nutrition 2019. A second study, also presented at Nutrition 2019, indicated that the order in which food is eaten may influence the onset of diabetes.” Click here for full story.
Lower Insulin Demand Associated With Gluten-Free Diet in Recent-Onset T1D
Endocrinology Advisor: “A gluten-free diet was associated with lower insulin demand and lower glycated hemoglobin (HbA1c) in newly diagnosed nonceliac pediatric patients with type 1 diabetes (T1D), according to study results presented at the American Diabetes Association 79th Scientific Sessions, held June 7 to 11, 2019, in San Francisco, California.” Click here for full story.
Terrifying Complications in 20 Year Olds With Type 2 Diabetes
Medscape: “Young people who were diagnosed with type 2 diabetes in their early teens had an ‘alarming’ high rate of diabetes-associated complications by the time they were in their mid-20s, according to new research.” Click here for full story.
EurekAlert: “People with undetected glucose disorders run a higher risk of both myocardial infarction and periodontitis, according to a study published in the journal Diabetes Care by researchers at Karolinska Institutet in Sweden. The results demonstrate the need of greater collaboration between dentistry and healthcare, say the researchers, and possibly of screening for diabetes at dental clinics.” Click here for full story.
Week of June 5, 2019
Diabetes Funding In Danger, Unless Congress Acts
WRBL.com: “The U.S. Centers for Disease Control and Prevention says Diabetes is the 7th leading cause of death in the United States and affects nearly 10 percent of the US population. The federal government supports important Diabetes Research at the National Institutes of Health—to the tune of $150-million a year. That funding will dry up unless Congress acts soon.” Click here for full story.
Depression Sufferers at Risk of Multiple Chronic Diseases
Science Daily: “Women who experience symptoms of depression are at risk of developing multiple chronic diseases, research led by The University of Queensland has found.” Click here for full story.
Mediterranean Diet, Improved Glycemic Control Provide Combined Cognitive Benefits
Healio: “Adults with type 2 diabetes may be able to improvements their cognitive abilities by incorporating a Mediterranean diet into their regular disease management regimens, according to findings published in Diabetes Care.” Click here for full story.
Type 2 Diabetes: High-Intensity Exercise May Restore Heart Function
Medical News Today: “Type 2 diabetes can sometimes result in a loss of heart function. However, the results of a new study suggest this function may be recovered through high-intensity exercise.” Click here for full story.
Human Insulin May Be a Lower-Cost Option for Some People With Diabetes
Harvard Health Publishing: “Of the estimated 23 million people in the US who have been diagnosed with diabetes, more than 30% take daily insulin injections to control their blood sugar (glucose) levels. Chances are good that someone you know has been startled by the high cost of this medication.” Click here for full story.
CDC: Fewer Adults Getting Diagnosed With Diabetes
WebMD: “It’s unclear why new cases of diabetes among U.S. adults are decreasing while obesity rates continue to climb, experts say. The number of new diabetes cases fell from 1.7 million in 2009 to 1.3 million in 2017, according to federal data released Tuesday, the Associated Press reported.” Click here for full story.
T1D Exchange Launches Online Registry to Drive Type 1 Diabetes Research
Yahoo Finance: “T1D Exchange today announced the official launch of the T1D Exchange Registry, an online longitudinal database of people living with type 1 diabetes (T1D). This pioneering effort provides a mobile-friendly platform for people throughout the U.S. to participate online and share information about their T1D in order to help researchers develop more targeted and effective approaches to treating and living with the disease.” Click here for full story.
X Cell in the Immune System Identified Which Could Be Linked to Type 1 Diabetes
Diabetes.co.uk: “Scientists have discovered a rogue immune cell coined the X cell which may be behind the development of type 1 diabetes. U.S. scientists from Johns Hopkins Medicine and IBM Research say further studies are needed to confirm the discovery, but claim they have “strong evidence” it could be a driver for type 1 diabetes.” Click here for full story.
Healthline: “A new treatment option — Eylea, from Regeneron Pharmaceuticals — has just been approved by the Food and Drug Administration (FDA) to treat all stages of diabetic retinopathy.” Click here for full story.
Week of May 29, 2019
High-Intensity Exercise May Restore Heart Function in People With Type 2 Diabetes
Science Daily: “University of Otago researchers have discovered that high-intensity exercise can reduce or reverse the loss in heart function caused by type 2 diabetes. The study found that three months of high-intensity interval training (HIIT) improved heart function in adults with type 2 diabetes, without any change in medications or diet.” Click here for full story.
The Washington Post: “The number of new diabetes cases among U.S. adults keeps falling, even as obesity rates climb, and health officials aren’t sure why. New federal data released Tuesday found the number of new diabetes diagnoses fell to about 1.3 million in 2017, down from 1.7 million in 2009.” Click here for full story.
Behavioral Therapy, Exercise Improves Depression in Type 2 Diabetes
Healio: “A combination of cognitive behavioral therapy and consistent exercise can be used to effectively treat major depressive disorder and depressive symptoms in those with type 2 diabetes, even in rural and underserved areas, according to findings published in Diabetes Care.” Click here for full story.
Providers, Regulators Explore Type 2 Therapies for Type 1 Diabetes
Healio: “For most children and adults with type 1 diabetes, day-to-day disease management remains difficult despite improvements in insulin formulations and delivery and advancements in diabetes technologies during the past decade.” Click here for full story.
A Potential Game Changer for Pets with Diabetes
TuftsNow: “When Olaf, a four-year-old Siberian husky, was diagnosed with diabetes in February, there wasn’t anything his owners, Gina and Brian Dacey, wouldn’t do to help him. “We’ve had him since he was a few weeks old, and he’s really still just a baby,” Gina Dacey said.” Click here for full story.
New Gene Variations for Type 2 Diabetes Found
WebMD: “It has long been known that lifestyle affects a person’s risk of developing type 2 diabetes. Now, researchers report that they have identified rare variants of four genes that may also play a part.” Click here for full story.
IBM Works on AI to Detect Chronic Diseases Like Parkinson’s, Diabetes
South China Morning Post: “IBM is banking on artificial intelligence (AI) and connected devices to find new ways to help people stay healthy, as the world copes with an ageing population and prevalent chronic diseases.” Click here for full story.
A Sweet Tale: The Son Who Reinvented Sugar to Help Diabetic Dad
The Guardian: “Javier Larragoiti was 18 when his father was diagnosed with diabetes. The teenager had just started a degree in chemical engineering in Mexico City. So he dedicated his studies to a side project: creating an acceptable alternative to help his father and millions of Mexicans like him avoid sugar.” Click here for full story.
Week of May 22, 2019
FDA Approves Aflibercept (Eylea) for Diabetic Retinopathy
Medscape: “The U.S. Food and Drug Administration (FDA) has approved aflibercept (Eylea, Regeneron) injection solution to treat all stages of diabetic retinopathy, the manufacturer has announced.” Click here for full story.
Research Reveals Insulin-Producing Beta Cells May Change Function in Diabetes
Science Daily: “A revolutionary new study using only materials derived from humans has revealed that insulin-producing beta cells can change their function in diabetes — and that this change may be reversible.” Click here for full story.
“Smart” Insulin Could Help Prevent Complications of Diabetes Treatment
Technology Networks: “UCLA bioengineers and their colleagues have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes… The treatment is being evaluated for potential clinical trials and, if successful, could change diabetes care. The study was published in the Proceedings of the National Academy of Sciences.” Click here for full story.
Type 1 Diabetes: New Pancreatic Cell Transplant System Shows Promise
Medical News Today: “Scientists have developed a way to increase the effectiveness of pancreatic islet transplantation, a promising therapy for type 1 diabetes. New findings could make pancreatic islet cell transplants more effective.
Immune rejection by the recipient is a major barrier to pancreatic islet transplants from donors becoming routinely available for the treatment of type 1 diabetes.” Click here for full story.
A Diabetes Patient Hurt By a Do-It-Yourself Pancreas Prompts an FDA Warning
LA Times: “The U.S. Food and Drug Administration warned diabetics against building their own artificial pancreas system to help control blood sugar levels after a patient using one suffered an accidental insulin overdose.” Click here for full story.
Few High-Risk Patients Attend Diabetes Prevention Programs
MedPage Today: “Among U.S. adults at high risk for type 2 diabetes, participation in prevention programs was “exceedingly low,” according to authors of a large, population-based survey study… Additionally, healthcare professionals commonly failed to refer high-risk individuals to such programs or to advise lifestyle modifications to prevent diabetes, researchers led by Mohammed Ali, MD, of the CDC’s National Center for Chronic Disease Prevention and Health Promotion in Atlanta, reported online in JAMA Network Open.” Click here for full story.
Week of May 15, 2019
Healio: “Motorists with diabetic peripheral neuropathy drive at slower speeds and are at increased risk for losing control of the vehicle compared with adults without peripheral nerve dysfunction; however, these drivers can improve with practice, according to results of a study conducted in the United Kingdom.” Click here for full story.
Science Daily: “Researchers used single-cell sequencing to identify a protein expressed uniquely by insulin-producing beta cells created from stem cells in the laboratory. By targeting the protein and adding a physical enrichment method, the purity of beta cells improved from 30 to 80%. Improved control over the beta cell production process will allow researchers to refine cell therapy for patients with type 1 diabetes.” Click here for full story.
Medical News Today: “Using simple, routine measures that are easy to obtain in a diabetes clinic, such as age at diagnosis and body mass index, can be an effective way to choose the best treatment for a person with type 2 diabetes.” Click here for full story.
Healio: “Nearly 5% of adults with type 2 diabetes and obesity may have obstructive sleep apnea, which is more prevalent among those with obesity regardless of diabetes status compared with the general population, according to findings published in Diabetic Medicine.” Click here for full story.
Medical News Today: “Previous research has suggested a link between the presence of diabetes and a person’s risk of cancer. Now, a large study in a Chinese population shows that type 2 diabetes is associated with an increased risk of cancer — though females and males seem to be more at risk of different forms.” Click here for full story.
Diabetes in Control: “Late-onset type 1 diabetes can be difficult to identify… This study aimed to determine the prevalence and characteristics of type 1 diabetes defined by severe endogenous insulin deficiency after age 30 and assess whether these individuals are identified and managed as having type 1 diabetes in clinical practice.” Click here for full story.
Week of May 8, 2019
AstraZeneca: “The U.S. Food and Drug Administration (FDA) has approved Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) extended release tablets as an oral adjunct treatment to diet and exercise to improve glycaemic control in adults with type-2 diabetes (T2D).” Click here for full story.
Pushing Early Beta-Cell Proliferation Can Halt Autoimmune Attack in Type 1 Diabetes Model
Science Daily: “Many in-development cures for type 1 diabetes have understandably focused on tackling the autoimmune aspect of the disease before figuring out a way to replace the destroyed beta cells. But what if focusing on the beta cells first could prevent their destruction altogether? Researchers have found that increasing the proliferation and turnover of beta cells before signs of type 1 diabetes could halt the development of the disease.” Click here for full story.
Type 2 Diabetes: Simple Method Can Help Tailor Treatment
Medical News Today: “Using simple, routine measures that are easy to obtain in a diabetes clinic, such as age at diagnosis and body mass index, can be an effective way to choose the best treatment for a person with type 2 diabetes.” Click here for full story.
Minnesota Lawmakers Look to Make Insulin More Affordable
Bustle: “A new insulin assistance program aimed at easing rising insulin costs passed the Minnesota House floor late last month. The Alec Smith Emergency Insulin Act, named after the 26-year-old Minnesotan who died from lack of insulin after aging off of his mother’s insurance, would create an emergency supply to help diabetics afford their insulin. The House passed the bill on April 25 as part of its health and human services omnibus bill.” Click here for full story.
Viola Davis on Her Prediabetes Diagnosis: ‘It’s Been Very Hard for Me’
AOL.com: “Viola Davis has chosen to live a life of significance. The Oscar-winning actress recognizes the immense privilege that comes with being as celebrated of an artist that she has become and, as she told AOL’s Gibson Johns during a recent sit-down interview during the Tribeca Film Festival, she sees that privilege as coming with an important responsibility to pay it forward.” Click here for full story.
Bustle: “According to a new study, intensive treatment for high blood pressure may reduce the risk of death from any cause, including cardiovascular disease, in people with type 2 diabetes.” Click here for full story.
Migraines May Reduce Your Chance of Getting Diabetes, According To This Study
Bustle: “A group of European researchers revealed the conclusions of their study into migraines the the end of 2018, and there were some surprisingly positive insights. At the end of their studies, the researchers concluded that they ‘observed a lower risk of developing type two diabetes for women with active migraine and a decrease in active migraine prevalence prior to diabetes diagnosis.'” Click here for full story.
Week of May 1, 2019
Time-Restricted Eating Shows Benefits for Blood Glucose
Science Daily: “By restricting the time period during which they could eat, researchers have seen promising results for controlling blood glucose levels in men at risk of type 2 diabetes. In a small study, researchers assessed the effects of time-restricted eating (TRE) in 15 men for one week.” Click here for full story.
Could Anti-Malarial Be Adjunctive T2D Therapy?
Medpage Today: “Hydroxychloroquine (HCQ, Plaquenil) might be a candidate as adjunctive therapy in type 2 diabetes, researchers reported here. Among adults patients with uncontrolled type 2 diabetes already on vildagliptin (Galvus, Zomelis) and metformin, HCQ significantly reduced HbA1c compared with baseline after 24 weeks (8.32% vs 7.11%, P=0.001), according to Amit Gupta, MD, of the G.D. Diabetes Institute in Kolkata, India, and colleagues.” Click here for full story.
Does Half the U.S. Population Have Diabetes or Prediabetes, as Tim Ryan Claimed?
Politifact: “If elected president, Democratic congressman Tim Ryan says he’d focus on a health care system that not only covers people when they are sick, but also keeps them healthy… ‘Half the country today has either diabetes or prediabetes,’ Ryan, a U.S. representative from Ohio, said at an April 11 WMUR town hall in Manchester. ‘A diabetic costs 2.3 times as much as every other patient. That is going to sink the health care system.'” Click here for full story.
Gestational Diabetes in India and Sweden
Medical Xpress: “Indian women are younger and leaner than Swedish women when they develop gestational diabetes, a new study from Lund University shows. The researchers also found a gene that increases the risk of gestational diabetes in Swedish women, but which, on the contrary, turned out to have a protective effect in Indian women.” Click here for full story.
Keto Diet: A ‘Cheat Day’ May Undo Benefits and Damage Blood Vessels
Medical News Today: “New research shows that people who follow a keto diet to lose weight or treat diabetes should avoid sudden spikes in blood sugar levels… One day may not make a big difference in the long-term, but a recent study from the University of British Columbia in Okanagan, Canada (UBCO), found that when it comes to the keto diet, a single dose of carbohydrates may have dangerous side effects.” Click here for full story.
Prescribed Statins Are Not Taken by 23.7% of Adults With Type 2 Diabetes
Healio: “Nearly 30% of adults with type 2 diabetes may not take all their medications as instructed, including nearly one-quarter of those prescribed statins, according to findings presented in Diabetes Care.” Click here for full story.
Medical Express: “Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md… Study coauthor Jane Lynch, M.D., FAAP, professor of pediatrics at UT Health San Antonio, said the drug, liraglutide, in combination with an existing medication, metformin, showed robust effect in treating children studied in the Ellipse trial.” Click here for full story.
Week of April 24, 2019
Metformin Use Linked to Worse Cognition, Vitamin B Deficiency
Medscape: “Metformin is associated with worse cognitive function in older adults, which could be explained by B-vitamin deficiency, new research suggests. ‘Fortified foods can provide a bioavailable source of B-vitamins and may be beneficial for maintaining better cognitive health in older people with or at risk for diabetes, but this requires confirmation in an intervention trial,’ Dr. Kirsty M. Porter of Ulster University in Coleraine, Northern Ireland, and colleagues conclude.” Click here for full story.
Diet Rich in Animal Protein is Associated With a Greater Risk of Early Death
Science Daily: “A diet rich in animal protein and meat in particular is not good for the health, a new study finds, providing further backing for earlier research evidence. Men who favored animal protein over plant-based protein in their diet had a greater risk of death in a 20-year follow-up than men whose diet was more balanced in terms of their sources of protein.” Click here for full story.
New Insight Into How Obesity, Insulin Resistance Can Impair Cognition
Science Daily: “The increased risk of cardiovascular disease (CVD) upon developing type 2 diabetes is similar in men and women, show data from a large UK-based study of newly diagnosed patients.” Click here for full story.
CVD Risk Similar in Men, Women With Diabetes, but Care Differs
Medscape: “The increased risk of cardiovascular disease (CVD) upon developing type 2 diabetes is similar in men and women, show data from a large UK-based study of newly diagnosed patients.” Click here for full story.
3 Ways Tech is Arming the Battle Against Diabetes
Innovation & Tech Today: “Thankfully, new technologies are making both types of diabetes easier to manage and less expensive to treat for both patients and medical professionals. “Diabetes is arguably the chronic condition most ripe for technological disruption,” says Dr. David Ahn, Endocrinologist and Program Director at the Mary and Dick Allen Diabetes Center in Newport Beach, California.” Click here for full story.
Medical News Today: “A new study shows that cheese improved insulin sensitivity in prediabetic rats, but industry funded the research… A recent study adds fuel to the fire by showing that both regular-fat and low-fat cheese improve insulin sensitivity in prediabetic rats. Dairy Farmers of Canada funded the study.” Click here for full story.
Endocrinology Advisor: “Metformin might improve whole-body and peripheral insulin sensitivity in overweight/obese adolescents with type 1 diabetes (T1D), according to study results published in The Journal of Clinical Endocrinology & Metabolism.” Click here for full story.
Week of April 18, 2019
Study Finds Diabetes Drug May Prevent, Slow Kidney Disease
APNews: “A drug that’s used to help control blood sugar in people with diabetes has now been shown to help prevent or slow kidney disease, which causes millions of deaths each year and requires hundreds of thousands of people to use dialysis to stay alive.” Click here for full story.
Eggs for Breakfast Benefits Those With Diabetes
Science Daily: “While some cereals may be the breakfast of champions, a professor suggests people with Type 2 Diabetes (T2D) should be reaching for something else. New research shows that a high-fat, low-carb breakfast (LCBF) can help those with T2D control blood sugar levels throughout the day.” Click here for full story.
A New Rx for Diabetes: Lighten Up
The New York Times: “In older patients, rigorous lowering of blood sugar may offer few benefits and pose unexpected risks.” Click here for full story.
Suffering From Gestational Diabetes? Here is What You Should Eat
The Health Site: “You can give birth to a healthy baby and reduce his risk of developing diabetes by managing your eating habits during gestational diabetes. Here, we tell you foods you can eat when you experience a surge in your blood glucose levels during pregnancy.” Click here for full story.
Week of April 2, 2019
Diabetes Treatment May Keep Dementia, Alzheimer’s at Bay
Science Daily: “A new study comparing people with diabetes, prediabetes and normal blood sugar finds that diabetes, left untreated, could mean a higher likelihood of developing dementia, including Alzheimer’s disease.” Click here for full story.
Keto Diet: New Study Unearths Sex Differences
Medical News Today: “In recent years, the ketogenic diet has become increasingly popular with people who want to lose weight quickly. A new study asks whether this dietary pattern works as well in females as it does in males.” Click here for full story.
Struggling to Stay Alive: Rising Insulin Prices Cause Diabetics to Go to Extremes
USA Today: “The escalating cost of insulin has desperate diabetics rationing medication, acquiring the drug from friends or getting it from Canada or Mexico.” Click here for full story.
Diabetes in Pregnancy Tied to Future Heart Disease Risk
Reuters: “Women with pregnancy-related diabetes are at higher risk for developing cardiovascular disease in the decade after childbirth, a research review suggests.” Click here for full story.
Week of March 27, 2019
Common Diabetes Test May Often Miss the Mark
WebMD: “A commonly used diabetes test may not spot the disease as well as an older test does, a new study suggests. The researchers said the newer test — called hemoglobin A1C — didn’t catch three-quarters of the diabetes diagnoses found by the older test — called an oral glucose tolerance test.” Click here for full story.
EU Approves AstraZeneca’s Drug for Adjunct Use in Type-1 Diabetes
Reuters: “British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement to insulin in adults with a rare type of the disease.” Click here for full story.
Race, Ethnicity Influence Fracture Risk in People With Diabetes
Medical Xpress: “Caucasians and Hispanics with diabetes have a greater risk of fracture compared to those without diabetes, while African Americans with diabetes have little to no additional fracture risk, according to a study to be presented Saturday, March 23 at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.” Click here for full story.
Treating Diabetes in Older Adults: Simpler Medication Regimens, Looser Glycemic Targets
Technology Networks: “Simplifying medication regimens and tailoring glycemic targets in older adults with diabetes improves adherence and avoids treatment-related complications, according to a Clinical Practice Guideline issued today by the Endocrine Society. The Society debuted the guideline during a press conference on the opening day of ENDO 2019, its annual meeting in New Orleans, La.” Click here for full story.
FDA Rejects Sanofi-Lexicon Oral Medication for Type 1 Diabetes
A Sweet Life: “The FDA has denied approval of Sanofi and Lexicon’s drug, sotagliflozin, as an add-on to insulin therapy in the treatment of Type 1 diabetes. This decision comes just a few months after an FDA advisory panel failed to reach a consensus over whether the drug’s benefits outweigh its risks.” Click here for full story.
Week of March 20, 2019
Cognitive Behavioral Therapy Reduces HbA1c, Distress Levels in Type 2 Diabetes
Healio: “Adults with type 2 diabetes may be able to achieve improved HbA1c levels and reduce depressive and distress symptoms when treated with personalized cognitive behavioral therapy, according to findings published in Diabetes Care.” Click here for full story.
AI Study of Risk Factors in Type 1 Diabetes
Science Daily: “A new review featuring in the European Journal of Endocrinology suggests that a stressful work environment may increase the risk of developing type 2 diabetes in women.” Click here for full story.
Type 2 Diabetes: Work Stress May Raise Risk in Women
Medical News Today: “In combination with conventional statistical methods, artificial intelligence (AI) has now been used in a study of risk factors in type 1 diabetes. The objective was to identify the most important indicators of elevated risk for cardiovascular disease and death.” Click here for full story.
Diabetes: Could Muscle Strength Lower Risk?
Medical News Today: “Many people worldwide have type 2 diabetes, a metabolic condition in which the body cannot properly regulate blood sugar levels. Experts already know that lack of physical activity can contribute to the risk of diabetes, but what type of exercise might lower it?” Click here for full story.
First Ever Oral Drug for Type 1 Diabetes May Be Coming Soon
NBC DFW: “Most people with diabetes have Type 2 diabetes, with an assortment of drugs at their disposal. But somewhere between 1.5 and 3 million Americans are living with Type 1 diabetes and their only drug option, insulin, is what keeps them alive. Now, in a world’s first, a new oral drug for this disease could change the way they manage their disease.” Click here for full story.
Week of March 13, 2019
Red Raspberries With Breakfast May Lead to Glycemic, Cardiometabolic Benefits
Healio: “Consuming red raspberries with breakfast could improve glycemic control in adults with overweight or obesity as well as prediabetes and insulin resistance, according to findings published in Obesity.” Click here for full story.
Gaining a Little Weight After Quitting Tobacco Is Offset by the Benefits for People With Diabetes
Science Daily: “People with diabetes who quit smoking tobacco may have a lower risk of heart attacks, strokes and other cardiovascular diseases — and weight gain following smoking cessation does not mitigate the health benefits among these patients, according to one study. Long-term, heavy smoking is a risk factor for cognitive decline, researchers found in an unrelated study.” Click here for full story.
Smoking, High Blood Pressure, Diabetes and Obesity Each Linked to Unhealthy Brains
Medical Xpress: “Factors that influence the health of our blood vessels, such as smoking, high blood and pulse pressures, obesity and diabetes, are linked to less healthy brains, according to research published in the European Heart Journal today.” Click here for full story.
How Diabetes Causes Muscle Loss
Science Daily: “Diabetes is associated with various health problems including decline in skeletal muscle mass. A research group revealed that elevation of blood sugar levels leads to muscle atrophy and that two proteins play key roles in this phenomenon.” Click here for full story.
A Diabetes Home Test Can Be a Waste of Time and Money
The New York Times: “More than 30 million people in the United States have diabetes. The vast majority of them have Type 2 diabetes. Some of those are testing their blood sugar at home, but the best research is telling us that they don’t need to — that in fact it’s a waste of money.” Click here for full story.
23andMe Plans New Genetic Test on Risk of Getting Diabetes
Fortune: “In an update to its genetic test, 23andMe is trying to make it easier for people to combat type 2 diabetes. When customers now purchase the company’s $199 Health & Ancestry Service test, they’ll get their saliva screened for type 2 diabetes, among a variety of other health conditions, the company said in a statement on Sunday.” Click here for full story.